Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dragnet for epilepsy genes

23.01.2015

An international team of scientists together with the University of Bonn Hospital have taken a new path in the research into causes of epilepsy: The researchers determined the networks of the active genes and, like a dragnet, looked for the "main perpetrators" using a computer model.

In doing so, they discovered the molecule sestrin-3 as a central switch. In animal models, the scientists were able to demonstrate that inhibition of sestrin-3 leads to a reduction in seizures. The results are now being presented in the renowned journal "Nature Communications".


Surgical specimen of an antiepileptic-resistant patient with temporal lobe epilepsy, which represents a unique access to the human brain tissue (upper left).

(c) Photo: Arbeitsgruppe Albert Becker/UKB

During an epileptic seizure, many nerve cells lose their regular rhythm and switch into a rapid rhythm. This results in seizures to the point of a loss of consciousness. The temporal lobes in the brain are most frequently the region in which such synchronous discharges occur.

"Drugs have the desired effect in only about two-thirds of patients with temporal lobe epilepsy," says Prof. Dr. med. Albert Becker from the Institute of Neuropathology of the University of Bonn Hospital. If no drug therapy helps, the seizure focus with the out-of-rhythm nerve cells are surgically removed as last therapy option. The epileptologists and neurosurgeons from the University of Bonn Hospital are specialized on such procedures to help the patient.

The brain tissue removed during these procedures gives science the unique opportunity to learn more about the causes and new treatment options for temporal lobe epilepsy. "Without tissue samples of this type, we would not have been able to conduct our large-scale investigation on the networks of genes and signal chains at all," says Prof. Becker. Together with their colleagues from Great Britain, the USA, Australia, Finland and Belgium, the scientists examined surgically removed tissue samples from the temporal lobes of a total of 129 epilepsy patients.

Sestrin-3 aberrantly activates brain and immune cells in epilepsy

The researchers from the University of Bonn Hospital determined which genes were active in the diseased nerve cells and other supporting brain cells. The scientists working with lead author Dr. Enrico Petretto from Imperial College London (England) entered these "suspects" into a computer model. As in the case of a dragnet, this allows connections between the conning tower and the signal chains thus set in motion to be sought. Just as the culprit is ultimately caught in the police's net due to certain manhunt connections, the scientists very similarly encountered an important switch during their analyses: Sestrin-3.

It is known that the molecule has an activating function in brain cells, among others, and also in immune cells. "Our data show: Sestrin-3 is centrally involved in the development and progression of temporal lobe epilepsy," explains Dr. Katharina Pernhorst, bioinformatician with Prof. Becker. The scientists proved this in mice and zebra fish whose brains demonstrate changes as in the case of human epilepsy. If "sestrin-3" is silenced, the severity and frequency of epileptic seizures is also reduced.

Starting point for novel therapies

The scientists see a platform in their novel method for further investigations. "This method broadens the view of individual gene/effect relationships to a systematic examination of the entire network," says Prof. Becker. In this way, the key positions in the interaction of signal chains and genes as well as with the immune system can be better detected. Moreover, the results show promising starting points for novel therapies. Conventional epilepsy drugs intervene in a regulatory way in the ion channels of the diseased nerve cells.

"However these drugs do not work in many patients because they develop resistance," reports Prof. Becker. "Sestrin-3" is not involved in the signal conduction via ion channels but rather, given the impact of stress, it upregulates the excitability of the nerve cells and also the activation of the immune cells. The errant regulation of the "sestrin-3" which leads to the development of epilepsy can presumably be held in check through suitable inhibitors without leading to drug resistance in the patient. "However, there is still a significant need for research until a suitable drug may be found," says Prof. Becker.

Publication: Systems-Genetics identifies Sestrin 3 as a proconvulsant gene network regulator in human epileptic Hippocampus, “Nature Communications”, DOI: 10.1038/ncomms7031

Media contact information:

Prof. Dr. med. Albert Becker
Institute of Neuropathology
University of Bonn Hospital
Tel. ++49-(0)228-28711352
E-Mail: Albert_Becker@uni-bonn.de

Johannes Seiler | idw - Informationsdienst Wissenschaft
Further information:
http://www.uni-bonn.de/

More articles from Health and Medicine:

nachricht Laser activated gold pyramids could deliver drugs, DNA into cells without harm
24.03.2017 | Harvard John A. Paulson School of Engineering and Applied Sciences

nachricht What does congenital Zika syndrome look like?
24.03.2017 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>